Morning Industry Symposium:
DCISionRT: Personalising treatment for women with DCIS
Supported by GenesisCare / PreludeDX
 |
|
Friday, October 14, 2022 Hall B (Great Hall 2)
07:30-08:30
Breakfast will be served from 07:00-07:30, half an hour prior to the start of the session.
Admission to this symposium is included as part of the congress registration.
| Chairperson: | Marcus Dreosti, Adelaide, Australia |
| Delivering precision medicine to women with DCIS in Australia: Clinical application and how it has changed the management of women with DCIS Bruce Mann, Melbourne, Australia |
|
| Science and clinical evidence: Consistent predictor of radiation therapy benefit Troy Bremer, Laguna Hills, CA, USA |
|
| Future advances in DCISionRT testing Frank A. Vicini, Royal Oak, MI, USA |
|
| Interim analysis of the PREDICT Registry Australia: Impact on treatment recommendations Yvonne Zissiadis, Perth, Australia |